{"id":8146,"date":"2026-10-15T12:00:24","date_gmt":"2026-10-15T10:00:24","guid":{"rendered":"https://briskr.nl/nl/?p=8146"},"modified":"2026-10-15T12:00:25","modified_gmt":"2026-10-15T10:00:25","slug":"nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech","status":"publish","type":"post","link":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/","title":{"rendered":"Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Health~Holland opent een nieuwe reguliere MKB Call voor innovatieve bedrijven in biotech, farma en medtech. Voor deze call is in totaal <strong>€8 miljoen aan PPS-subsidie</strong> beschikbaar om kansrijke innovaties verder richting toepassing te brengen.</p>\n\n\n\n<p class=\"wp-block-paragraph\">De call biedt mogelijkheden voor mkb-bedrijven die werken aan veelbelovende innovaties binnen de Life Sciences &amp; Health-sector. Het gaat daarbij om innovaties in <strong>Technology Readiness Level (TRL) 4 tot en met 6</strong>: ontwikkelingen die de eerste onderzoeksfase voorbij zijn en verder moeten worden ontwikkeld en gevalideerd.</p>\n\n\n\n<p class=\"wp-block-paragraph\">De reguliere MKB Call vormt een aanvulling op de eerder aangekondigde thematische MKB Call Arbeidsbesparende Technologie, waarvoor €4,5 miljoen beschikbaar is. Innovaties hoeven voor deze nieuwe call dus niet specifiek gericht te zijn op arbeidsbesparing.</p>\n\n\n\n<h3 class=\"wp-block-heading\">Wat biedt de MKB Call?</h3>\n\n\n\n<p class=\"wp-block-paragraph\">Projecten kunnen een maximale looptijd hebben van twee jaar. Binnen een project kan maximaal <strong>€300.000 PPS-subsidie voor het mkb</strong> worden aangevraagd. Voor de betrokken onderzoeksorganisatie is maximaal <strong>€150.000 PPS-subsidie</strong> beschikbaar.</p>\n\n\n\n<p class=\"wp-block-paragraph\">De call kan daarmee interessant zijn voor innovatieve mkb-bedrijven die samen met een onderzoeksorganisatie een volgende stap willen zetten in de ontwikkeling van hun technologie, product of oplossing.</p>\n\n\n\n<h3 class=\"wp-block-heading\">Deadline: 20 november 2026</h3>\n\n\n\n<p class=\"wp-block-paragraph\">De volledige aanvraag moet uiterlijk <strong>20 november 2026 om 17.00 uur CET</strong> zijn ingediend.</p>\n\n\n\n<p class=\"wp-block-paragraph\">Wil je weten of jouw innovatie binnen deze call past of meer lezen over de voorwaarden en aanvraagprocedure? Bekijk dan de volledige informatie over de <a href=\"https://www.health-holland.com/calls/mkb-call-2027\" data-type=\"link\" data-id=\"https://www.health-holland.com/calls/mkb-call-2027\"><strong>MKB Call op de website van Health~Holland</strong>.</a></p>\n\n\n\n<p class=\"wp-block-paragraph\">Voor vragen over de call kan ook contact worden opgenomen met Health~Holland via <a href=\"mailto:tki@health-holland.com\"><strong>tki@health-holland.com</strong></a>.</p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"1000\" src=\"https://briskr.nl/wp-content/uploads/2026/10/Call-Health-Holland.jpeg\" alt=\"\" class=\"wp-image-8147\" srcset=\"https://briskr.nl/wp-content/uploads/2026/10/Call-Health-Holland.jpeg 800w, https://briskr.nl/wp-content/uploads/2026/10/Call-Health-Holland-240x300.jpeg 240w, https://briskr.nl/wp-content/uploads/2026/10/Call-Health-Holland-768x960.jpeg 768w, https://briskr.nl/wp-content/uploads/2026/10/Call-Health-Holland-460x575.jpeg 460w, https://briskr.nl/wp-content/uploads/2026/10/Call-Health-Holland-480x600.jpeg 480w\" sizes=\"auto, (max-width: 800px) 100vw, 800px\" /></figure>\n","protected":false},"excerpt":{"rendered":"<p>Health~Holland opent een nieuwe reguliere MKB Call voor innovatieve bedrijven in biotech, farma en medtech. Voor deze call is in totaal €8 miljoen aan PPS-subsidie&#46;&#46;&#46;</p>\n","protected":false},"author":3,"featured_media":8148,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5],"tags":[8],"jku-businessfase":[11],"class_list":["post-8146","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-finance","tag-health","jku-businessfase-start-up"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https://yoast.com/product/yoast-seo-wordpress/ -->\n<title>Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech - Briskr</title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" />\n<link rel=\"canonical\" href=\"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/\" />\n<meta property=\"og:locale\" content=\"nl_NL\" />\n<meta property=\"og:type\" content=\"article\" />\n<meta property=\"og:title\" content=\"Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech - Briskr\" />\n<meta property=\"og:description\" content=\"Health~Holland opent een nieuwe reguliere MKB Call voor innovatieve bedrijven in biotech, farma en medtech. Voor deze call is in totaal €8 miljoen aan PPS-subsidie&#046;&#046;&#046;\" />\n<meta property=\"og:url\" content=\"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/\" />\n<meta property=\"og:site_name\" content=\"Briskr\" />\n<meta property=\"article:published_time\" content=\"2026-10-15T10:00:24+00:00\" />\n<meta property=\"article:modified_time\" content=\"2026-10-15T10:00:25+00:00\" />\n<meta property=\"og:image\" content=\"https://briskr.nl/wp-content/uploads/2026/10/Health-Holland-Call-biotech-Briskr-.jpg\" />\n\t<meta property=\"og:image:width\" content=\"1190\" />\n\t<meta property=\"og:image:height\" content=\"399\" />\n\t<meta property=\"og:image:type\" content=\"image/jpeg\" />\n<meta name=\"author\" content=\"m.snieder\" />\n<meta name=\"twitter:card\" content=\"summary_large_image\" />\n<meta name=\"twitter:label1\" content=\"Written by\" />\n\t<meta name=\"twitter:data1\" content=\"m.snieder\" />\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" />\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" />\n<script type=\"application/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\/\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/#article\",\"isPartOf\":{\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/\"},\"author\":{\"name\":\"m.snieder\",\"@id\":\"https:\\/\\/briskr.nl\\/#\\/schema\\/person\\/6ce32fb04331a55974c8330578191f8a\"},\"headline\":\"Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech\",\"datePublished\":\"2026-10-15T10:00:24+00:00\",\"dateModified\":\"2026-10-15T10:00:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/\"},\"wordCount\":247,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\/\\/briskr.nl\\/#organization\"},\"image\":{\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\/\\/briskr.nl\\/wp-content\\/uploads\\/2026\\/10\\/Health-Holland-Call-biotech-Briskr-.jpg\",\"keywords\":[\"Health\"],\"articleSection\":[\"Funding &amp; Finance\"],\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/\",\"url\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/\",\"name\":\"Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech - Briskr\",\"isPartOf\":{\"@id\":\"https:\\/\\/briskr.nl\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\/\\/briskr.nl\\/wp-content\\/uploads\\/2026\\/10\\/Health-Holland-Call-biotech-Briskr-.jpg\",\"datePublished\":\"2026-10-15T10:00:24+00:00\",\"dateModified\":\"2026-10-15T10:00:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/#primaryimage\",\"url\":\"https:\\/\\/briskr.nl\\/wp-content\\/uploads\\/2026\\/10\\/Health-Holland-Call-biotech-Briskr-.jpg\",\"contentUrl\":\"https:\\/\\/briskr.nl\\/wp-content\\/uploads\\/2026\\/10\\/Health-Holland-Call-biotech-Briskr-.jpg\",\"width\":1190,\"height\":399},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\/\\/briskr.nl\\/funding-finance\\/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\/\\/briskr.nl\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\/\\/briskr.nl\\/#website\",\"url\":\"https:\\/\\/briskr.nl\\/\",\"name\":\"Briskr\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\/\\/briskr.nl\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\/\\/briskr.nl\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\/\\/briskr.nl\\/#organization\",\"name\":\"Briskr\",\"url\":\"https:\\/\\/briskr.nl\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\/\\/briskr.nl\\/#\\/schema\\/logo\\/image\\/\",\"url\":\"https:\\/\\/briskr.nl\\/wp-content\\/uploads\\/2022\\/02\\/Briskr-favicon.png\",\"contentUrl\":\"https:\\/\\/briskr.nl\\/wp-content\\/uploads\\/2022\\/02\\/Briskr-favicon.png\",\"width\":512,\"height\":512,\"caption\":\"Briskr\"},\"image\":{\"@id\":\"https:\\/\\/briskr.nl\\/#\\/schema\\/logo\\/image\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\/\\/briskr.nl\\/#\\/schema\\/person\\/6ce32fb04331a55974c8330578191f8a\",\"name\":\"m.snieder\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\/\\/secure.gravatar.com\\/avatar\\/77e2b630902623d6f0fe87b74aceaafe5fc6a4812b79cf40d3a7e5b4763d09c6?s=96&d=mm&r=g\",\"url\":\"https:\\/\\/secure.gravatar.com\\/avatar\\/77e2b630902623d6f0fe87b74aceaafe5fc6a4812b79cf40d3a7e5b4763d09c6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\/\\/secure.gravatar.com\\/avatar\\/77e2b630902623d6f0fe87b74aceaafe5fc6a4812b79cf40d3a7e5b4763d09c6?s=96&d=mm&r=g\",\"caption\":\"m.snieder\"},\"url\":\"https:\\/\\/briskr.nl\\/author\\/m-snieder\\/\"}]}</script>\n<!-- / Yoast SEO plugin. -->","yoast_head_json":{"title":"Nieuwe subsidiemogelijkheid voor innovatieve mkb-bedrijven in de biotechnologie, farmaceutische industrie en medische technologie - Briskr","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/","og_locale":"nl_NL","og_type":"article","og_title":"Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech - Briskr","og_description":"Health~Holland opent een nieuwe reguliere MKB Call voor innovatieve bedrijven in biotech, farma en medtech. Voor deze call is in totaal €8 miljoen aan PPS-subsidie&#46;&#46;&#46;","og_url":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/","og_site_name":"Briskr","article_published_time":"2026-10-15T10:00:24+00:00","article_modified_time":"2026-10-15T10:00:25+00:00","og_image":[{"width":1190,"height":399,"url":"https://briskr.nl/wp-content/uploads/2026/10/Health-Holland-Call-biotech-Briskr-.jpg","type":"image/jpeg"}],"author":"m.snieder","twitter_card":"summary_large_image","twitter_misc":{"Written by":"m.snieder","Est. reading time":"2 minutes"},"schema":{"@context":"https://schema.org","@graph":[{"@type":"Article","@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/#article","isPartOf":{"@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/"},"author":{"name":"m.snieder","@id":"https://briskr.nl/nl/#/schema/person/6ce32fb04331a55974c8330578191f8a"},"headline":"Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech","datePublished":"2026-10-15T10:00:24+00:00","dateModified":"2026-10-15T10:00:25+00:00","mainEntityOfPage":{"@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/"},"wordCount":247,"commentCount":0,"publisher":{"@id":"https://briskr.nl/nl/#organization"},"image":{"@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/#primaryimage"},"thumbnailUrl":"https://briskr.nl/wp-content/uploads/2026/10/Health-Holland-Call-biotech-Briskr-.jpg","keywords":["Health"],"articleSection":["Funding &amp; Finance"],"inLanguage":"nl-NL","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/#respond"]}]},{"@type":"WebPage","@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/","url":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/","name":"Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech - Briskr","isPartOf":{"@id":"https://briskr.nl/nl/#website"},"primaryImageOfPage":{"@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/#primaryimage"},"image":{"@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/#primaryimage"},"thumbnailUrl":"https://briskr.nl/wp-content/uploads/2026/10/Health-Holland-Call-biotech-Briskr-.jpg","datePublished":"2026-10-15T10:00:24+00:00","dateModified":"2026-10-15T10:00:25+00:00","breadcrumb":{"@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/#primaryimage","url":"https://briskr.nl/wp-content/uploads/2026/10/Health-Holland-Call-biotech-Briskr-.jpg","contentUrl":"https://briskr.nl/wp-content/uploads/2026/10/Health-Holland-Call-biotech-Briskr-.jpg","width":1190,"height":399},{"@type":"BreadcrumbList","@id":"https://briskr.nl/nl/funding-finance/nieuwe-subsidiekans-voor-innovatieve-mkbers-in-biotech-farma-en-medtech/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://briskr.nl/nl/"},{"@type":"ListItem","position":2,"name":"Nieuwe subsidiekans voor innovatieve mkb’ers in biotech, farma en medtech"}]},{"@type":"WebSite","@id":"https://briskr.nl/nl/#website","url":"https://briskr.nl/nl/","name":"Briskr","description":"","publisher":{"@id":"https://briskr.nl/nl/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://briskr.nl/nl/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https://briskr.nl/nl/#organization","name":"Briskr","url":"https://briskr.nl/nl/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https://briskr.nl/nl/#/schema/logo/image/","url":"https://briskr.nl/wp-content/uploads/2022/02/Briskr-favicon.png","contentUrl":"https://briskr.nl/wp-content/uploads/2022/02/Briskr-favicon.png","width":512,"height":512,"caption":"Briskr"},"image":{"@id":"https://briskr.nl/nl/#/schema/logo/image/"}},{"@type":"Person","@id":"https://briskr.nl/nl/#/schema/person/6ce32fb04331a55974c8330578191f8a","name":"m.snieder","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https://secure.gravatar.com/avatar/77e2b630902623d6f0fe87b74aceaafe5fc6a4812b79cf40d3a7e5b4763d09c6?s=96&d=mm&r=g","url":"https://secure.gravatar.com/avatar/77e2b630902623d6f0fe87b74aceaafe5fc6a4812b79cf40d3a7e5b4763d09c6?s=96&d=mm&r=g","contentUrl":"https://secure.gravatar.com/avatar/77e2b630902623d6f0fe87b74aceaafe5fc6a4812b79cf40d3a7e5b4763d09c6?s=96&d=mm&r=g","caption":"m.snieder"},"url":"https://briskr.nl/nl/author/m-snieder/"}]}},"_links":{"self":[{"href":"https://briskr.nl/nl/wp-json/wp/v2/posts/8146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https://briskr.nl/nl/wp-json/wp/v2/posts"}],"about":[{"href":"https://briskr.nl/nl/wp-json/wp/v2/types/post"}],"author":[{"embeddable":true,"href":"https://briskr.nl/nl/wp-json/wp/v2/users/3"}],"replies":[{"embeddable":true,"href":"https://briskr.nl/nl/wp-json/wp/v2/comments?post=8146"}],"version-history":[{"count":1,"href":"https://briskr.nl/nl/wp-json/wp/v2/posts/8146/revisions"}],"predecessor-version":[{"id":8149,"href":"https://briskr.nl/nl/wp-json/wp/v2/posts/8146/revisions/8149"}],"wp:featuredmedia":[{"embeddable":true,"href":"https://briskr.nl/nl/wp-json/wp/v2/media/8148"}],"wp:attachment":[{"href":"https://briskr.nl/nl/wp-json/wp/v2/media?parent=8146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https://briskr.nl/nl/wp-json/wp/v2/categories?post=8146"},{"taxonomy":"post_tag","embeddable":true,"href":"https://briskr.nl/nl/wp-json/wp/v2/tags?post=8146"},{"taxonomy":"jku-businessfase","embeddable":true,"href":"https://briskr.nl/nl/wp-json/wp/v2/jku-businessfase?post=8146"}],"curies":[{"name":"wp","href":"https://api.w.org/{rel}","templated":true}]}}